Jennifer E Miller, PhD
Associate Professor of Medicine (General Medicine)Cards
About
Research
Publications
Featured Publications
The Critical Shortage of Iodinated Contrast Material — Will Value Prevail?
Tu LH, Miller JE, Forman HP. The Critical Shortage of Iodinated Contrast Material — Will Value Prevail? The New England Journal Of Medicine 2022, 387: 491-493. PMID: 35704416, DOI: 10.1056/nejmp2206996.Peer-Reviewed Original ResearchAccess to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials
Ramachandran R, Ross JS, Miller JE. Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials. JAMA Network Open 2021, 4: e2134233. PMID: 34792596, PMCID: PMC8603077, DOI: 10.1001/jamanetworkopen.2021.34233.Peer-Reviewed Original ResearchEvaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs
Miller JE, Mello MM, Wallach JD, Gudbranson EM, Bohlig B, Ross JS, Gross CP, Bach PB. Evaluation of Drug Trials in High-, Middle-, and Low-Income Countries and Local Commercial Availability of Newly Approved Drugs. JAMA Network Open 2021, 4: e217075. PMID: 33950209, PMCID: PMC8100865, DOI: 10.1001/jamanetworkopen.2021.7075.Peer-Reviewed Original ResearchConceptsFDA approvalHigh-income countriesDrug approvalIncome countriesNovel drugsDrug Administration (FDA) drug approvalsRegulatory agency websitesCross-sectional analysisProportion of drugPrimary outcomeFDA drug approvalsProportion of countriesDrug trialsMAIN OUTCOMEUS FoodClinical researchCountry income levelLow-income countriesMarketing approvalTrialsGoogle ScholarDrugsDrug companiesApprovalMedian
2025
Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals
Lee C, Gross C, Miller J. Physical Accessibility of Medicines in Countries Hosting Trials for FDA Approvals. JAMA Internal Medicine 2025, 186 PMID: 41247741, PMCID: PMC12624461, DOI: 10.1001/jamainternmed.2025.6060.Peer-Reviewed Original ResearchCross-sectional retrospective analysisFDA approvalMarketing authorizationYears of FDA approvalRegulatory agency websitesLower-middle-income countriesHigh-income countriesCross-sectional studyStatistically significant improvementMedian timeDrug regulatory agency websitesAccessibility of medicinesClinical trialsDrug AdministrationAnalysis of phase 2Drugs@FDA databaseProportion of medicinesExploitation concernsMiddle-income countriesTime pointsMain OutcomesFDAEthical guidanceUS FoodPhysical accessThe Ethics of Industry-Funded Speakers’ Bureaus—How They Disseminate Innovation and Could Corrupt Medicine
Miller J, Robertson C. The Ethics of Industry-Funded Speakers’ Bureaus—How They Disseminate Innovation and Could Corrupt Medicine. JAMA Network Open 2025, 8: e2532331. PMID: 40960835, DOI: 10.1001/jamanetworkopen.2025.32331.Peer-Reviewed Original ResearchToward Patient-Centered AI Fact Labels: Leveraging Extrinsic Trust Cues
Yoo D, Stroud A, Zhu X, Miller J, Barry B. Toward Patient-Centered AI Fact Labels: Leveraging Extrinsic Trust Cues. 2025, 2025: 676-690. PMID: 41019587, PMCID: PMC12461688, DOI: 10.1145/3715336.3735758.Peer-Reviewed Original ResearchExamining equity-related eligibility criteria in clinical trials supporting 2022 US drug approvals
Sliwinski K, Miller J, Lynch H. Examining equity-related eligibility criteria in clinical trials supporting 2022 US drug approvals. PLOS ONE 2025, 20: e0324807. PMID: 40560878, PMCID: PMC12194189, DOI: 10.1371/journal.pone.0324807.Peer-Reviewed Original ResearchConceptsFood and Drug AdministrationEligibility criteriaClinical trialsUS Food and Drug AdministrationDrug approvalFood and Drug Administration guidanceInstitutional review boardFood and Drug Administration's Center for Drug EvaluationDrug AdministrationCenter for Drug EvaluationReview boardDrug evaluationSocioeconomic statusTrialsTherapeutic biologicsEligibilityAgeApprovalMolecular entitiesPregnancyRepresentation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time.
Miller J, Pelletiers W, Gross C, Mello M, Ramachandran R, Schwartz J, Suttiratana S, Varma T, Ross J. Representation of Women, Older Adults, and Racial and Ethnic Minoritized Patients in Pivotal Trials for US Food and Drug Administration Novel Oncology Therapeutic Approvals, 2012-2021: Bright Spot Trials and Trends Over Time. JCO Oncology Practice 2025, op2400563. PMID: 40493876, PMCID: PMC12360498, DOI: 10.1200/op-24-00563.Peer-Reviewed Original ResearchFood and Drug AdministrationOncology therapeuticsLatino patientsBlack patientsTherapeutic approvalsOlder adultsRetrospective cross-sectional studyUS Food and Drug AdministrationTrial characteristicsMinoritized patientsUS patient populationSpot trialsPivotal trialsPatient demographicsPatient populationRepresentative patientsTrial enrollmentUS Census dataDrug AdministrationPatientsStudy of trialsTrialsOncologyWomenClinical trial diversityPatient information needs for transparent and trustworthy cardiovascular artificial intelligence: A qualitative study
Stroud A, Minteer S, Zhu X, Ridgeway J, Miller J, Barry B. Patient information needs for transparent and trustworthy cardiovascular artificial intelligence: A qualitative study. PLOS Digital Health 2025, 4: e0000826. PMID: 40258073, PMCID: PMC12011294, DOI: 10.1371/journal.pdig.0000826.Peer-Reviewed Original ResearchArtificial intelligenceInformation needsHealthcare AI systemsInformation deliveryPatients' information needsCalibrate trustTrustworthy implementationAI systemsAsynchronous online focus groupsPatient-centered engagementCore information needsOnline focus groupsAI toolsHealthcare experiencesModel documentationHealth systemCardiovascular careClinical encountersPatient careFocus groupsProvision informationQualitative studyAI useInformation patientsPatient informationKey information influencing patient decision-making about AI in healthcare: A survey experiment (Preprint)
Zhu X, Stroud A, Minteer S, Yoo D, Ridgeway J, Mooghali M, Miller J, Barry B. Key information influencing patient decision-making about AI in healthcare: A survey experiment (Preprint). Journal Of Medical Internet Research 2025 DOI: 10.2196/75615.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
- November 18, 2025Source: U.S. News & World Report
Drugs Rarely Become Available In Lower-Income Countries Where They're Tested, Study Says
- November 17, 2025
Do All Countries Benefit From Clinical Trials?
- May 08, 2025Source: The New York Times
Can a Photograph Reveal Your Biological Age?
- February 27, 2023
Increasing Diversity in Clinical Trials: A Q&A With Jennifer Miller, PhD
Get In Touch
Contacts
Mailing Address
Yale School of Medicine
367 Cedar Street, Harkness 4th floor
New Haven, CT 06520
United States
Events
Jan 20268Tomorrow
Yale Only Jennifer E Miller, PhD